drugset / Trial / NCT01471899

Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment

NCT01471899

Phase 3 Completed 78 enrolled EMS
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drugs in the treatment of patients diagnosed with moderate to severe back pain treatment.

Timeline

Start
2013-03
Primary completion
2013-12
Completion
2014-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Tromethamine Small molecule 10 unknown Oral
Comparator Naproxen Small molecule 2 unknown

Indications

No indication recorded.